Engaño, Hermellina E.

HRN: 28-85-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2026
CEFTRIAXONE 1G (VIAL)
04/16/2026
04/22/2026
IVTT
2g
Od
Uti
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: